What is BariaTek?
BariaTek, founded by Truffle Capital and based in Paris, France, is a medical technology company focused on addressing obesity through innovative, minimally invasive endoscopic approaches. The company's dedication to developing advanced solutions positions it as a key player in the gastrointestinal health sector.
How much funding has BariaTek raised?
BariaTek has raised a total of $1.6M across 1 funding round:
Other Financing Round
$1.6M
Other Financing Round (2023): $1.6M with participation from Bpifrance
Key Investors in BariaTek
Bpifrance
Bpifrance, established in 2012, is a French public investment bank that provides financing, guarantees, and equity to companies at all stages of development. They support innovation, international expansion, and export activities, offering a comprehensive suite of services including consulting and acceleration programs for businesses.
What's next for BariaTek?
The recent major enterprise-level funding infusion suggests BariaTek is poised for significant scaling and further research and development. This capital injection will likely accelerate the company's efforts to bring its obesity-focused endoscopic solutions to a wider market, potentially marking a new phase of growth and market penetration.
See full BariaTek company page
